Continuous Wound Infiltration for Diminution of Post-surgery Pain After Caesarean Section
Status:
Withdrawn
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
A medical approach that warrants continuous and reliable local administration of non-opioid
analgesic drugs might substantially improve post-surgery pain management in CS, while
decreasing the necessity of staff-dependent invasive procedures and the probability of
untoward effects following systemic drug exposure. ReadyfusOR® is a formulation comprising a
Ropivacain-loaded single-use pump which has been approved for regional application of the
analgesic drug, also comprising obstetric interventions. There is, however, scarce scientific
information on the efficacy and benefit of this anesthetic drug formulation for pain
management following CS by means of continuous wound infiltration.